6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Bispecific Antibodies and Antibody–Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCs

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Molecular Cancer Therapeutics
          Mol Cancer Ther
          American Association for Cancer Research (AACR)
          1535-7163
          1538-8514
          April 02 2017
          April 20 2017
          : 16
          : 4
          : 681-693
          Article
          10.1158/1535-7163.MCT-16-0658
          28108597
          31927a1c-70f6-4863-bdb5-1864f45e9315
          © 2017
          History

          Comments

          Comment on this article